Ergoteles LLC Aerie Pharmaceuticals Inc Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $2.73 Million - $6.52 Million	428,184 New	428,184 $6.48 Million
Q2 2022 Aug 12, 2022	SELL	$4.95 - $9.16 $239,580 - $443,344	-48,400 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $45,120 - $78,400	-8,000 Reduced 14.18%	48,400 $440,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $395,928 - $751,812	56,400 New	56,400 $396,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.